Lowenstein advised Hildred Capital Management and Crown Laboratories on the deal, while Gibson, Dunn & Crutcher advised StriVectin and L Catterton. Hildred Capital Management (Hildred) and […]
Crown Laboratories’ Acquisition of StriVectin
Indorama’s $1.3 Billion Acquisition of Ultrapar’s Chemical Unit
Lowenstein, Beccar Varela, and Mattos Filho, Veiga Filho, Marrey Jr. E Quiroga advised Indorama Ventures on the deal. Skadden, Stocche Forbes, BMA – Barbosa, Müssnich, Aragão […]
Indorama Ventures’ Acquisition of CarbonLite’s Texas PET Recycling
Lowenstein represented Indorama Ventures in the transaction. Indorama Ventures (BKK: IVL), a global chemicals producer, completed its acquisition of CarbonLite Holdings’ facility in Texas as part of […]
Halma’s Acquisition of PeriGen
Lowenstein Sandler represents PeriGen Inc. in the transaction. Halma plc executed the acquisition of PeriGen Inc. (PeriGen), a leading provider of perinatal health care software solutions. PeriGen’s […]